In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Blueberry Therapeutics Ltd.

www.blueberrytherapeutics.com

Latest From Blueberry Therapeutics Ltd.

Finance Watch: Vaccinex, Aridis Launch August's First US IPOs As The Summer Simmer Slows

The summer slowdown finally seems to have hit the US biopharma IPO market; after a hot July with nine offerings, there were just two during the first half of August. Also, Zogenix leads recent follow-ons with a $312m offering; venture capital planted in UK biotechs – Orchard and Blueberry.

Financing Business Strategies

GSK Spin-Off Launches KaNDy To Tackle Key Symptoms Of Menopause

NeRRe Therapeutics has set up a new entity around a drug which it believes could be an effective alternative to hormone replacement therapy for hot flashes that may rapidly reduce debilitating sleep disturbance.

StartUps and SMEs Gynecology & Urology

Avacta To Evaluate Affimers As Checkpoint Inhibitors, Anticoagulants

After raising $34 million from Britain’s stock market, the U.K. biotech now plans to develop its Affimer proteins as therapeutics as well as research reagents, to enable two complementary strands of business.

BioPharmaceutical United Kingdom

Start-Up Previews, February 2015

This Month's Profile Group, BioHub At Alderley Park, features profiles of Absynth Biologics, Blueberry Therapeutics, Molplex Pharmaceuticals, and OncoTherics. Plus these Start-Ups Across Health Care: Centerline Biomedical, Laurimed, and Portal Instruments.

BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Dermatology
  • Infectious & Viral Diseases
  • Inflammation
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Blueberry Therapeutics Ltd.
  • Senior Management
  • John Ridden, DPhil, CEO
    Juergen Dobmeyer, MD, Acting CMO
    David Cook, PhD, CSO
    Mark Hollingworth, Fin. Dir.
  • Contact Info
  • Blueberry Therapeutics Ltd.
    Phone: 1625 238781
    BioHub at Alderley Park, Mereside
    Alderley Edge
    Cheshire, SK10 4TG
    UK
UsernamePublicRestriction

Register